4.45 USD
↗ 0.13 (3.01%)AT CLOSE (11:59 AM EDT)
CAMP4 Therapeutics Corporation Common Stock
CAMPNASDAQ • USD
4.45
↘ 0.00 (0.11%)
POST MARKET (AS OF 04:10 PM EDT)
Post Market
AS OF 04:10 PM EDT
4.45
↘ 0.00 (0.11%)
Market: OPEN
Shares of CAMP4 Therapeutics Corporation Common Stock (CAMP) are trading at $4.45. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (15475.3%) and a bearish Death Cross on the long-term moving averages. On the valuation front, CAMP trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 25, 2026.
Open?$4.40
High?$4.60
Low?$4.33
Prev. Close?$4.32
Volume?184.5K
Avg. Volume?215.3K
VWAP?$4.48
Rel. Volume?0.86x
Bid / Ask
Bid?$3.68 × 100
Ask?$5.47 × 100
Spread?$1.79
Midpoint?$4.58
Valuation & Ratios
Market Cap?271.1M
Shares Out?62.8M
Float?28.8M
Float %?55.5%
P/E Ratio?N/A
P/B Ratio?-391.19
EPS?-$1.71
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
Themes
Employees
48
Market Cap
271.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-11
Address
100 TALCOTT AVENUE
WATERTOWN, MA 02472
Phone: 617-651-8867
WATERTOWN, MA 02472
Phone: 617-651-8867
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.34Distress
Confidence?47%Low
Short InterestHigh
Short % of Float?4.43%Low
Short Interest?1.3M
Days to Cover?5.2
Free Float28.8M
Avg Daily Volume244.3K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.70Strong
Quick Ratio?4.70Strong
Cash Ratio?4.51Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-391.19CHEAP▾
S&P97
P/S?64.30HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
S&P97
EV/Sales?43.81HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?15,475.3%STRONG▾
Peers50
S&P97
ROA?-114.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28720000
Enterprise Value?$184.7M
Fundamentals ratios updated end of day